![Christopher Leamon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Leamon
Director Técnico/Científico/I+D en
FUSN PHAR
.
Perfil
Christopher P.
Leamon is Chief Scientific Officer at Fusion Pharmaceuticals, Inc. since 2021.
Formerly, Dr. Leamon was Executive Director-Radioligand Drug Discovery at Novartis Institutes for Biomedical Research, Inc., Principal at Glaxo Wellcome Plc, Vice President-Research at Endocyte, Inc. from 1999 to 2011, and Vice President-Discovery Research at Advanced Accelerator Applications USA, Inc. Education includes undergraduate studies at Baldwin-Wallace College and a doctorate from Purdue University.
Cargos activos de Christopher Leamon
| Empresas | Cargo | Inicio |
|---|---|---|
| FUSN PHAR | Director Técnico/Científico/I+D | 02/11/2021 |
Antiguos cargos conocidos de Christopher Leamon.
| Empresas | Cargo | Fin |
|---|---|---|
Advanced Accelerator Applications USA, Inc.
 Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes MNM diagnostic and therapeutic products | Corporate Officer/Principal | - |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
| ENDOCYTE, INC. | Director Técnico/Científico/I+D | - |
Formación de Christopher Leamon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
27
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Baldwin-Wallace College
 Baldwin-Wallace College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Advanced Accelerator Applications USA, Inc.
Advanced Accelerator Applications USA, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes MNM diagnostic and therapeutic products | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Leamon
